Le Lézard
Classified in: Covid-19 virus

Global Laboratory Balances and Scales Market (2021 to 2028) - Proliferation of Pharmaceutical Sector in Emerging Markets Presents Opportunities - ResearchAndMarkets.com


The "Laboratory Balances and Scales Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Type, End User, and Geography" report has been added to ResearchAndMarkets.com's offering.

According to this report the market is expected to reach US$ 2,131.14 million by 2028 from US$ 1,463.53 million in 2021; it is estimated to grow at a CAGR of 5.5% from 2021 to 2028. The report highlights trends prevailing in the market, and the factors driving and hindering the market growth. The market growth is primarily attributed to rapid growth of pharmaceutical and biotechnology industry and increasing number of research pipeline of pharma-biotech companies and contract research organizations. However, the limited replacement rate among end users is likely to hamper the growth of the market to a certain extent.

Laboratory balances and scales are high performance instruments that measure accurate readings in various environments. Laboratory balances are specifically used to measure mass of the substance, while laboratory scales are utilized to measure weight of the substances. These scales and balances are classified based on weighing capacity. Weighing of materials play a vital role in research and development as well as production monitoring and quality control. Based on end user, the laboratory balances and scales market is segmented into pharmaceutical/biotechnology products testing laboratories, cosmeceutical products laboratories, academic institutes, and research laboratories. In 2020, the pharmaceutical/biotechnology products testing laboratories segment held the largest share of the market. Also, the same segment is estimated to register the highest CAGR of 6.7% during the forecast period.

The laboratory balances and scales market is witnessing substantial decline amid the COVID-19 pandemic. Certain factors such as decline in pharmaceutical production and drug discovery activities are hampering the adoption of laboratory balances and scales worldwide. However, research activities associated with the COVID-19 are expected to have marginal positive impact on the market.

Reasons to Buy

Market Dynamics

Drivers

Restraint

Opportunity

Future Trend

Companies Mentioned

For more information about this report visit https://www.researchandmarkets.com/r/pxx8pi


These press releases may also interest you

at 20:09
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of QuidelOrtho Corporation between February 18, 2022 and April 1, 2024, both dates inclusive (the "Class Period") of the important June 11, 2024 lead...

at 19:30
Results  For the year ended January 31, 2024, the Company's revenues decreased by $139,027,000 to $578,945,000 compared to $717,972,000 recorded for the year ended January 31, 2023, a decrease of 19.4%. This decrease is mainly explained by the...

at 19:30
Lendistry announces today that it has been selected to administer the Entertainment Business Interruption Fund Program (BIF) to support small Los Angeles County businesses serving the entertainment industry. This program, created and funded through...

at 18:40
Rocky Mountain Liquor Inc. (the "Company" or "Rocky Mountain"), listed on the TSX Venture Exchange (the "Exchange"), today reported its financial results for the full year and fourth quarter ended December 31, 2023.KEY...

at 18:05
Guanajuato Silver Company Ltd. (the "Company" or "GSilver") announces a brokered, best-efforts Listed Issuer Financing Exemption private placement (the "Offering") consisting of units of the Company (the "Units") at a price of C$0.20 per Unit (the...

at 17:25
Customers Bancorp, Inc. : First Quarter 2024 Highlights Q1 2024 net income available to common shareholders was $45.9 million, or $1.40 per diluted share; ROAA was 0.94% and ROCE was 12.08%. Q1 2024 core earnings* were $46.5 million, or $1.42...



News published on and distributed by: